Amicus Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
VANGUARD GROUP INC | 11/13/2024 | 28.80 M | $307.59 M | 0.74% | 9.45% |
PERCEPTIVE ADVISORS LLC | 11/14/2024 | 28.06 M | $299.65 M | 0.00% | 9.21% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 26.11 M | $278.82 M | 100.00% | 8.57% |
WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 23.96 M | $255.94 M | 13.53% | 7.87% |
AVORO CAPITAL ADVISORS LLC | 11/14/2024 | 23.18 M | $247.51 M | -15.42% | 7.61% |
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 11/08/2024 | 15.58 M | $166.43 M | 19.84% | 5.11% |
JPMORGAN CHASE & CO | 12/26/2024 | 12.92 M | $137.98 M | -13.12% | 4.24% |
STATE STREET CORP | 11/14/2024 | 10.97 M | $117.17 M | -0.42% | 3.60% |
REDMILE GROUP, LLC | 11/14/2024 | 8.25 M | $88.07 M | -22.17% | 2.71% |
PALO ALTO INVESTORS LP | 11/14/2024 | 8.15 M | $86.99 M | -9.80% | 2.67% |
MACQUARIE GROUP LTD | 11/14/2024 | 6.97 M | $74.44 M | -2.13% | 2.29% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 6.60 M | $70.50 M | 1.24% | 2.17% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 6.34 M | $67.67 M | -52.12% | 2.08% |
MORGAN STANLEY | 11/14/2024 | 4.22 M | $45.02 M | -15.57% | 1.38% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 4.04 M | $43.17 M | 56.60% | 1.33% |
AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 3.90 M | $41.70 M | -0.48% | 1.28% |
NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 3.65 M | $38.96 M | 92.06% | 1.20% |
CITADEL ADVISORS LLC | 11/14/2024 | 3.63 M | $38.77 M | 20.33% | 1.19% |
FIERA CAPITAL CORP | 11/01/2024 | 3.21 M | $34.31 M | -39.16% | 1.05% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 3.19 M | $34.07 M | 115.22% | 1.05% |
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11/12/2024 | 3.16 M | $33.75 M | 4.62% | 1.04% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 2.67 M | $28.49 M | 10.01% | 0.88% |
INVESCO LTD. | 11/12/2024 | 2.55 M | $27.23 M | -0.12% | 0.84% |
NOVO HOLDINGS A/S | 10/24/2024 | 2.50 M | $26.70 M | 0.00% | 0.82% |
BLACKSTONE INC. | 11/14/2024 | 2.47 M | $26.35 M | 0.00% | 0.81% |
ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 2.04 M | $21.76 M | 141.06% | 0.67% |
BALYASNY ASSET MANAGEMENT L.P. | 11/14/2024 | 1.91 M | $20.45 M | 71.42% | 0.63% |
ABRDN PLC | 10/25/2024 | 1.81 M | $19.32 M | 9.05% | 0.59% |
PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 1.63 M | $17.43 M | -61.39% | 0.53% |
GRANITE INVESTMENT PARTNERS, LLC | 11/12/2024 | 1.50 M | $16.05 M | 83.01% | 0.49% |
STEMPOINT CAPITAL LP | 11/13/2024 | 1.48 M | $15.83 M | -0.89% | 0.49% |
PANAGORA ASSET MANAGEMENT INC | 11/13/2024 | 1.43 M | $15.27 M | -0.11% | 0.47% |
HUDSON BAY CAPITAL MANAGEMENT LP | 11/13/2024 | 1.43 M | $15.22 M | 33.49% | 0.47% |
VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 1.39 M | $14.84 M | 7.88% | 0.46% |
PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.34 M | $14.33 M | -3.46% | 0.44% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 11/14/2024 | 1.28 M | $13.64 M | -1.44% | 0.42% |
POINT72 ASSET MANAGEMENT, L.P. | 11/14/2024 | 1.27 M | $13.53 M | 100.00% | 0.42% |
VICTORY CAPITAL MANAGEMENT INC | 11/05/2024 | 1.26 M | $13.44 M | -44.67% | 0.41% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 11/14/2024 | 1.25 M | $13.35 M | 2.60% | 0.41% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 1.08 M | $11.58 M | 100.00% | 0.36% |
PRIMECAP MANAGEMENT CO/CA/ | 11/08/2024 | 1.03 M | $10.99 M | -2.25% | 0.34% |
WOODLINE PARTNERS LP | 11/14/2024 | 1.03 M | $10.98 M | 100.00% | 0.34% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 1.02 M | $10.84 M | -18.46% | 0.33% |
RICE HALL JAMES & ASSOCIATES, LLC | 10/28/2024 | 972,138 | $10.38 M | -0.02% | 0.32% |
NEW YORK STATE COMMON RETIREMENT FUND | 10/28/2024 | 917,514 | $9.80 M | -40.85% | 0.30% |
OSTERWEIS CAPITAL MANAGEMENT INC | 11/14/2024 | 884,820 | $9.45 M | 28.34% | 0.29% |
EXODUSPOINT CAPITAL MANAGEMENT, LP | 11/12/2024 | 817,007 | $8.73 M | 4.54% | 0.27% |
FMR LLC | 11/13/2024 | 802,056 | $8.57 M | -22.75% | 0.26% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 769,300 | $8.22 M | 21.72% | 0.25% |
NEUBERGER BERMAN GROUP LLC | 11/14/2024 | 761,730 | $8.14 M | -0.01% | 0.25% |
Amicus Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 385 institutional investors and hedge funds held shares of Amicus Therapeutics, Inc.. The most heavily invested institutionals were:
Sage Capital Advisors,llc: 0
CVA Family Office, LLC: 0
VANGUARD GROUP INC: 28.8 M
PERCEPTIVE ADVISORS LLC: 28.06 M
BlackRock Funding, Inc. /DE: 26.11 M
WELLINGTON MANAGEMENT GROUP LLP: 23.96 M
100.70% of Amicus Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 372.13 M shares in the last 24 months. This purchase volume represents approximately $3.42 B in transactions.